Your browser doesn't support javascript.
loading
PPM1D mutations appear in complete remission after exposure to chemotherapy without predicting emerging AML relapse.
Al Hinai, Adil S A; Grob, Tim; Rijken, Melissa; Kavelaars, François G; Zeilemaker, Annelieke; Erpelinck-Verschueren, Claudia A J; Sanders, Mathijs A; Löwenberg, Bob; Jongen-Lavrencic, Mojca; Valk, Peter J M.
Afiliação
  • Al Hinai ASA; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Grob T; National Genetic Center, Ministry of Health, Muscat, Sultanate of Oman.
  • Rijken M; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Kavelaars FG; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Zeilemaker A; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Erpelinck-Verschueren CAJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Sanders MA; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Löwenberg B; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Jongen-Lavrencic M; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Valk PJM; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Leukemia ; 35(9): 2693-2697, 2021 09.
Article em En | MEDLINE | ID: mdl-33589749
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Proteína Fosfatase 2C / Mutação / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Revista: Leukemia Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Proteína Fosfatase 2C / Mutação / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Revista: Leukemia Ano de publicação: 2021 Tipo de documento: Article